A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant (2015)
- Authors:
- Autor USP: FERREIRA, JULIO CESAR BATISTA - ICB
- Unidade: ICB
- DOI: 10.1146/annurev-pharmtox-010814-124915
- Subjects: ANATOMIA; ALDEIDOS; ESOFAGO; ESOFAGOPATIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Annual review of Pharmacology and Toxicology
- ISSN: 1545-4304
- Volume/Número/Paginação/Ano: v. 55, p. 107-127, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
GROSS, Eric R. et al. A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annual review of Pharmacology and Toxicology, v. 55, p. 107-127, 2015Tradução . . Disponível em: https://doi.org/10.1146/annurev-pharmtox-010814-124915. Acesso em: 08 out. 2024. -
APA
Gross, E. R., Zambelli, V. O., Small, B. A., Ferreira, J. C. B., Chen, C. -H., & Mochly-Rosen, D. (2015). A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annual review of Pharmacology and Toxicology, 55, 107-127. doi:10.1146/annurev-pharmtox-010814-124915 -
NLM
Gross ER, Zambelli VO, Small BA, Ferreira JCB, Chen C-H, Mochly-Rosen D. A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant [Internet]. Annual review of Pharmacology and Toxicology. 2015 ; 55 107-127.[citado 2024 out. 08 ] Available from: https://doi.org/10.1146/annurev-pharmtox-010814-124915 -
Vancouver
Gross ER, Zambelli VO, Small BA, Ferreira JCB, Chen C-H, Mochly-Rosen D. A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant [Internet]. Annual review of Pharmacology and Toxicology. 2015 ; 55 107-127.[citado 2024 out. 08 ] Available from: https://doi.org/10.1146/annurev-pharmtox-010814-124915 - Participação da isoforma proteína quinase C 'beta' II na insuficiência cardíaca
- New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
- Mitochondrial quality control in cardiac diseases
- Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities
- Alcohol consumption and vascular disease: other points to consider
- In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
- Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities
- Mitochondrial dysfunction in degenerative diseases
Informações sobre o DOI: 10.1146/annurev-pharmtox-010814-124915 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
